Understanding how the urothelium grows and differentiates is central to understanding a number of bladder diseases. Being able to modulate these processes would allow us to improve treatment of urinary tract abnormalities in children and adults. Preliminary evidence in our laboratory suggests that Fibroblast Growth Factor (FGF)-10 plays an important role in regulating DNA synthesis of urothelial cells, a crucial process involved in control of growth, differentiation, and repair of the urothelium. This process is described by a complex network of paracrine action that originates in the mesenchyme but acts on the urothelium. Disruption of this process in FGF10-null mice alters the differentiation of bladder urothelial cells and results in an abnormal transitional epithelium typified by incomplete stratification. Other processes involved in the control of growth and differentiation of the urothelium include cytokines and growth factors of various types. We propose to attack the FGF-10 part of these processes because a) nothing is known about the biology of FGF-10 in the bladder and b) an understanding of how FGF-10 works in conjunction with these other processes will allow us to develop new and innovative methods to strengthen our translational approach to the problem of bladder and urinary tract disease. In order to achieve these goals, we have established specific aims for this period of support to better understand how FGF-10 functions in the context of a dynamic steady-state interrelationship that stimulates the progression of the urothelial cell cycle. Two mechanisms for how FGF-10 triggers proliferation are hypothesized: 1) the translocation of FGF-10 into urothelial cell nuclei and 2) a signalling cascade that begins with the heparin-dependent phosphorylation of tyrosine residues of surface receptors. We propose that negligible levels of FGF-10 define the normal urothelial phenotype -that of quiescence. During proliferative phases, levels of FGF-10 rise at the urothelial cell surface and/or within urothelial cell nuclei. Since our preparations of recombinant FGF-10 induce urothelial cell proliferation in animals, we eventually plan to evaluate the feasiblity of FGF-10 therapy in repairing the urothelium in clinical settings such as urethral trauma stricture disease and trauma. This study of the basic mechanisms of action will set the stage for later clinical use. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK062251-01A1
Application #
6619966
Study Section
Special Emphasis Panel (ZRG1-UROL (01))
Program Officer
Mullins, Christopher V
Project Start
2003-03-01
Project End
2007-12-31
Budget Start
2003-03-01
Budget End
2003-12-31
Support Year
1
Fiscal Year
2003
Total Cost
$257,939
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Zhang, Hongyong; Aina, Olulanu H; Lam, Kit S et al. (2012) Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach. Urol Oncol 30:635-45
Zhang, Dianzhong; Hudson, Amber E; Delostrinos, Catherine F et al. (2011) Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream. Am J Physiol Renal Physiol 300:F475-87
Hicks, Bryson G; Lopez, Erasmo A; Eastman Jr, Rocky et al. (2011) Differential affinity of vitronectin versus collagen for synthetic biodegradable scaffolds for urethroplastic applications. Biomaterials 32:797-807
Eastman Jr, Rocky; Leaf, Elizabeth M; Zhang, Dianzhong et al. (2010) Fibroblast growth factor-10 signals development of von Brunn's nests in the exstrophic bladder. Am J Physiol Renal Physiol 299:F1094-110
Lendvay, Thomas S; Sweet, Robert; Han, Chang-Hee et al. (2007) Compensatory paracrine mechanisms that define the urothelial response to injury in partial bladder outlet obstruction. Am J Physiol Renal Physiol 293:F1147-56
Kosman, Jeffrey; Carmean, Nicole; Leaf, Elizabeth M et al. (2007) Translocation of fibroblast growth factor-10 and its receptor into nuclei of human urothelial cells. J Cell Biochem 102:769-85
Hudson, Amber E; Carmean, Nicole; Bassuk, James A (2007) Extracellular matrix protein coatings for facilitation of urothelial cell attachment. Tissue Eng 13:2219-25
Carmean, N; Kosman, J W; Leaf, E M et al. (2007) Immortalization of human urothelial cells by human papillomavirus type 16 E6 and E7 genes in a defined serum-free system. Cell Prolif 40:166-84
Zhang, Dianzhong; Kosman, Jeffrey; Carmean, Nicole et al. (2006) FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tract. Am J Physiol Renal Physiol 291:F481-94